The Heart Rhythm Society announced plans to develop a first-of-its-kind Pulsed Field Ablation data collection platform (registry), sponsored in part by Johnson & Johnson MedTech, a global leader in the treatment of heart rhythm disorders. The platform will offer a national, technology-enabled infrastructure designed to advance clinical evidence, improve patient outcomes, and support post-market surveillance for atrial fibrillation PFA procedures.

Read the full press release here: https://bit.ly/4qijiQQ

Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].